Snapshot · Foreign US-listed · generated 2026-11-11 20:45 UTC

NAMS — NewAmsterdam Pharma Company N.V.

N/A · Quality 38/100

NAMS - NewAmsterdam Pharma Company N.V.
Data generated 2026-11-11 20:45 UTC (nightly scan, universe: Foreign US-listed).
Price: 20.75 USD
Valuation: N/A
Value Score: 23.4
Quality: 38/100
Moat score: 0 (erosion: none)
N/A - Quality 38/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/NAMS
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

20.75

Intrinsic value

no positive per-share earnings - the P/E-blend method needs a profit to value

Margin of safety

Implied growth (reverse DCF)

a described calculation from stated inputs, not a forecast

Value Score

23.4

Quality

Psychology

27.3

Discovery

13.3

price/volume attention only

Moat score

erosion: none

Value Score: bottom 30% of Foreign US-listed · Quality: bottom 10%

Open the interactive Deep Dive for NAMS →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/NAMS - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

What is NewAmsterdam Pharma Company N.V.'s Value Score?

NewAmsterdam Pharma Company N.V.'s Value Score is 23.4 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number. This is a described calculation from public data, not a recommendation.